** Endo International's shares ENDP.O fall as much as
27.5% to 37 cents
** Shares drop on WSJ report that the drugmaker is
considering filing for Chapter 11 bankruptcy without first
reaching agreements with junior creditors and opioid plaintiffs
** Report says ENDP's move is a means to restructure its
$8.1 billion of debt and thousands of outstanding lawsuits,
citing people familiar with the matter (https://on.wsj.com/3AEAutc)
** Endo, which has been weighed down by litigation over the
opioid epidemic in the United States, has discussed the
possibility of filing for bankruptcy protection in several
public filings
** Last month, ENDP missed a $38 million interest payment,
amid talks with a group of unsecured bondholders lobbying to
keep the company out of bankruptcy urn:newsml:reuters.com:*:nL1N2YH1MB
** OxyContin-maker Purdue Pharma and Mallinckrodt MCDG.MU ,
a generic opioid manufacturer, are other pharmaceutical
companies that have filed for Chapter 11 to address opioid
claims
** Including session losses, stock is down 89% this year
(Reporting by Nandhini Srinivasan in Bengaluru)
((Nandhini.srinivasan@thomsonreuters.com))